化工社化工社 化学情報印刷レポート · 研究参考用
HCID 193313作成日:2026年10月25日
7-オキソデヒドロエピアンドロステロン
7-オキソ-デヒドロエピアンドロステロン · 7-オキソ-DHEA · (3aS,3bR,7S,9aR,9bS,11aS)-7-ヒドロキシ-9a,11a-ジメチル-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-シクロペンタ[a]フェナントレン-1,4-ジオン · 7-オキソデヒドロエピアンドロステロン · 3β-ヒドロキシ-5-アンドロステン-7,17-ジオン · 3β-ヒドロキシアンドロスタ-5-エン-7,17-ジオン · 7-ケトデヒドロエピアンドロステロン · 7-KETO DHEA
https://huagongshe.com/ja/chemical/193313
識別子と物理属性
| CAS No. | 566-19-8 |
|---|
| 分子式 | C19H26O3 |
|---|
| 平均分子量 | 302.4 g/mol |
|---|
| 単同位体質量 | 302.18819469 g/mol |
|---|
| SMILES | C[C@]12CC[C@H](O)CC1=CC(=O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12 |
|---|
| InChIKey | KPRGOTLNGIBVFL-GINZOMEDSA-N |
|---|
| PubChem CID | 193313 |
|---|
| ChEMBL | CHEMBL1875999 |
|---|
| ChEBI | CHEBI:183808 |
|---|
| EC No. | 111-754-6 |
|---|
| DTXSID | DTXSID801024029 |
|---|
| 現地名 | 7-オキソデヒドロエピアンドロステロン |
|---|
化学・物理的性質
| XLogP | 2 |
|---|
| 極性表面積 | 54.4 |
|---|
| 水素結合供与体数 | 1 |
|---|
| 水素結合受容体数 | 3 |
|---|
| 回転可能結合数 | 0 |
|---|
| 重原子数 | 22 |
|---|
| 形式電荷 | 0 |
|---|
| 複雑度 | 577 |
|---|
| 融点 | 245-248 °C |
|---|
| 沸点 | 477.1±45.0 °C(Predicted) |
|---|
| 密度 | 1.19±0.1 g/cm3(Predicted) |
|---|
| 溶解度 | DMF: 25 mg/mlDMF:PBS(pH 7.2)(1:1): 0.5 mg/mlDMSO: 15 mg/mlEthanol: 10 mg/ml |
|---|
| 外観・状態 | A crystalline solid |
|---|
| pKa(酸解離定数) | 14.67±0.60(Predicted) |
|---|
| InChI | InChI=1/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-14,17,20H,3-9H2,1-2H3/t12-,13-,14-,17-,18-,19-/s3 |
|---|
| InChIKey | KPRGOTLNGIBVFL-YQJRJXGQNA-N |
|---|
| SMILES | C[C@]12CC[C@H](O)CC1=CC(=O)[C@@]1([H])[C@]3([H])CCC(=O)[C@@]3(C)CC[C@]21[H] |&1:1,4,11,13,19,23,r| |
|---|
| CAS データベース | 566-19-8(CAS DataBase Reference) |
|---|
安全性と法規制
| GHS 分類 | DangerH351 (100%): Suspected of causing cancer [Warning Carcinogenicity]P203, P280, P318, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|
| Hazard Classes and Categories | Carc. 2 (100%) |
|---|
用途
説明
7-Ketodehydroepiandrosterone (7-Keto-dehydroepiandrosterone; 7-keto-DHEA), chemically known under 3-acetyl-7-oxo-dehydroepiandrosterone, is a naturally occurring metabolite of the steroid hormone dehydroepiandrosterone (DHEA) and is marketed as such an anti-obesity dietary supplement. The synthesis of 7-keto-DHEA begins with an irreversible hydroxylation of DHEA in the position C7 by cytochrome P450 7B1 (CYP7B1) under the formation of 7 α-hydroxy-dehydroepiandrosterone (7 α-OH-DHEA). β-hydroxysteroid dehydrogenase type 1 (11 β-HSD 1) then catalyzes the interconversion of 7 α-OH-DHEA and 7 β-hydroxy-dehydroepiandrosterone (7 β-OH-DHEA) through a 7-keto-DHEA intermediary. DHEA is a "parent hormone" produced by glands near the kidneys. However, unlike DHEA, 7-keto-DHEA is not converted to steroid hormones such as androgen and estrogen. Taking 7-keto-DHEA by mouth or applying it to the skin does not increase the level of steroid hormones in the blood. People take 7-keto-DHEA for obesity, muscle strength, anxiety, depression, and other conditions. However, there is no good scientific evidence to support these uses[1].